In addition to the eight research programs identified in our Cancer Center Support Grant, the Stanford Cancer Institute supports a number of key initiatives designed to foster discovery, application and translation of scientific knowledge. Inter-disciplinary teams of collaborative investigators partner to solve some of the most challenging questions in cancer research. Some of our key initiatives include:
The Stanford Brain Metastases Consortium
The Stanford Brain Metastases Consortium is a unique partnership between scientists, physicians and surgeons from across the Stanford community, bringing together experts in research and clinical care of brain metastases. The goal of the Consortium is to increase the number of available clinical trials and collaborative publications, and to enhance patients' experience through a team-based approach to care.
Stanford Pancreas Cancer Research Group (SPCRG)
The members of this group are committed to advancing research and care for pancreatic cancer. SPCRG is comprised of an inter-disciplinary team of collaborative investigators from multiple Schools at Stanford.
After Cancer: Stanford Cancer Survivorship Program
After Cancer's mission is to improve the experience, and outcomes, of patients and caregivers throughout all phases of their cancer journey by advancing survivorship research, clinical care and education.
Wipe Out Melanoma - California
Wipe Out Melanoma - California is a project focused on primary and secondary prevention research with a particular emphasis on Hispanic and low socioeconomic status Caucasian groups who are at the highest risk for advanced disease. It is a joint partnership with Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai, and part of a larger nationwide War on Melanoma- Federation of States.
Clinical Trials for Rare Cancers
The SCI offers specialized expertise in clinical trials for multiple rare cancers, including nasopharyngeal cancer.